Table 2.
CR rates in patients with different clinicopathological characteristics.
| Characteristic | Number of CR | Number of non-CR | CR rate (%) | p value |
|---|---|---|---|---|
| Lugano stage | ||||
| Stage I | 9 | 1 | 90.0 | 0.062 |
| Stage II and IV | 11 | 9 | 50.5 | |
|
| ||||
| IPI score | ||||
| 0–2 | 16 | 5 | 76.2 | 0.104 |
| 3–5 | 4 | 5 | 44.4 | |
|
| ||||
| Histological subtype | ||||
| GCB | 9 | 4 | 69.2 | 0.554 |
| Non-GCB | 11 | 6 | 64.7 | |
|
| ||||
| Intestinal involvement | ||||
| Involved | 6 | 7 | 46.2 | 0.045∗ |
| Not involved | 14 | 3 | 82.4 | |
|
| ||||
| Ki67 | ||||
| <80% | 9 | 3 | 75.0 | 0.350 |
| ≥80% | 11 | 7 | 61.1 | |
∗ p < 0.05 indicates a statistically significant difference between groups. GCB: germinal center B-cell-like.